Kenneth Locke

Ken Locke joined Carisma Therapeutics in June 2020. He has over 25 years of pharmaceutical and biotechnology experience including discovery, laboratory automation, sourcing/contracting strategy, supply chain and manufacturing. Prior to joining Carisma, Ken served as Global Head of Cell Therapy External Manufacturing and Strategic Sourcing at Bristol Myers Squibb (formerly Celgene/Juno Therapeutics) where he was responsible for all external manufacturing operations for plasmid, viral vector and cell processing. Prior to BMS, Ken was Executive Director at Novartis supporting global materials and services sourcing for all Technical R&D as well as Cell and Gene Therapies. He started his pharmaceutical career as a discovery researcher at 3-Dimensional Pharmaceuticals and held research roles of increasing responsibility at Rhône-Poulenc Rorer, DuPont Pharmaceuticals and Bristol Myers Squibb.